Hunan Jingfeng Pharmaceutical Co.,Ltd. (SHE:000908)

SHE:000908 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	85.52	13.17	181.39	172.18	164.2
Cash & Short-Term Investments	85.52	13.17	181.39	172.18	164.2
Cash Growth	549.63%	-92.74%	5.35%	4.86%	-69.34%
Accounts Receivable	70.13	85.92	197.02	217.24	465.31
Other Receivables	11.82	31.95	27.16	91.22	84.43
Receivables	81.96	117.86	224.18	308.46	549.74
Inventory	44.18	64.58	120.37	155.4	232.39
Other Current Assets	15.53	18.15	45.35	41.48	75.55
Total Current Assets	227.19	213.76	571.3	677.51	1,022
Property, Plant & Equipment	328.67	434.21	553.48	726.1	1,014
Long-Term Investments	42.78	44.72	50.46	103.86	166.77
Goodwill	0.12	0.12	33.03	33.03	71.98
Other Intangible Assets	53.45	61.55	101.66	100.47	94.62
Long-Term Deferred Tax Assets	2.49	10.41	30.3	23.57	64.34
Long-Term Deferred Charges	111.12	107.86	106.49	117.4	253.76
Other Long-Term Assets	174.17	187.72	10.82	10.36	2.85
Total Assets	939.98	1,060	1,458	1,792	2,690
Accounts Payable	102.96	148.94	138.54	122.97	186.25
Accrued Expenses	14.53	105.76	109.51	63.29	19.1
Short-Term Debt	191.67	195.82	213.02	475.67	940
Current Portion of Long-Term Debt	262.76	299.42	299.8	387.68	388.18
Current Portion of Leases	-	3.67	3.63	1.3	-
Current Income Taxes Payable	34.88	0.62	4.93	1.17	1.25
Current Unearned Revenue	16.28	24.19	26.2	25.22	22.07
Other Current Liabilities	281.65	263.12	287.71	283.8	301.81
Total Current Liabilities	904.73	1,042	1,083	1,361	1,859
Long-Term Debt	-	72.28	72.52	1	-
Long-Term Leases	6.71	22.69	9.84	7.87	-
Long-Term Unearned Revenue	17.15	20.73	24.81	51.01	124.17
Long-Term Deferred Tax Liabilities	2.91	7.7	6.45	5.27	8.86
Other Long-Term Liabilities	23.61	49.08	58.93	38.34	60.14
Total Liabilities	955.11	1,214	1,256	1,465	2,052
Common Stock	416.69	416.69	416.69	416.69	416.69
Additional Paid-In Capital	617.75	617.75	617.75	617.42	647.53
Retained Earnings	-933.99	-1,065	-850.2	-708.89	-545.23
Comprehensive Income & Other	-18.65	-18.59	-19.46	-18.83	1.04
Total Common Equity	81.8	-49.49	164.79	306.39	520.03
Minority Interest	-96.93	-104.19	36.85	21.34	118.15
Shareholders' Equity	-15.13	-153.68	201.63	327.73	638.18
Total Liabilities & Equity	939.98	1,060	1,458	1,792	2,690
Total Debt	461.14	593.88	598.81	873.52	1,328
Net Cash (Debt)	-375.62	-580.72	-417.42	-701.35	-1,164
Net Cash Per Share	-0.43	-0.66	-0.47	-0.80	-1.32
Filing Date Shares Outstanding	881.14	879.77	879.77	879.77	879.77
Total Common Shares Outstanding	881.14	879.77	879.77	879.77	879.77
Working Capital	-677.54	-827.79	-512.06	-683.57	-836.79
Book Value Per Share	0.09	-0.06	0.19	0.35	0.59
Tangible Book Value	28.23	-111.16	30.1	172.89	353.44
Tangible Book Value Per Share	0.03	-0.13	0.03	0.20	0.40
Buildings	-	337.65	401.86	527.56	677.09
Machinery	-	291.5	412.21	385.78	570.1
Construction In Progress	-	70.22	88.37	87.72	82.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.